EPL Limited Q2FY27: Revenue Surges 30%, EBITDA Grows 17.6% Amidst Global Expansion
EPL Limited reported a 30.0% revenue increase to ₹15,674 million for Q2FY27, with EBITDA growing 17.6% to ₹2,960 million. The 'Personal Care & Beyond' segment showed strong growth, now forming 55% of revenue. The company achieved EcoVadis Platinum rating and aims for high teens growth. Merger with Indovida is progressing with an expected completion in Q4 FY27.
The significant revenue and EBITDA growth, coupled with strategic initiatives like the merger and strong sustainability achievements, are material to the company's financial performance and market position.
The company reported strong revenue and EBITDA growth, highlighted positive regional performance, and emphasized progress in sustainability initiatives and strategic growth drivers. The outlook for future growth and the ongoing merger progress are also positive indicators.
EPL Limited announced strong financial results for the quarter and half-year ended September 30, 2026. The company reported a significant 30.0% revenue growth, with underlying revenue growth at 20.3%, indicating robust performance in its core business. All regions contributed to this growth, with EAP leading at 40.2%, followed by Europe (30.4%), AMESA (28.0%), and Americas (25.3%).
The company's underlying EBITDA margin stood at a healthy 20.4%, reflecting a 17.6% increase compared to the previous year, demonstrating resilience despite commodity inflation. Reported EBITDA was 18.9% due to pricing pass-through. Profit After Tax (PAT) saw a growth of 5.6%, though impacted by higher depreciation, increased effective tax rate, and foreign exchange losses. The company anticipates PAT growth recovery in the coming quarters. Return on Capital Employed (ROCE) remained strong at 18.2%.
EPL highlighted its strategic initiatives, including investments in new technologies and capabilities, and operational enhancements. The 'Personal Care & Beyond' segment, encompassing Beauty & Cosmetics and Pharma, now constitutes 55% of total revenue and grew by 32.4% year-on-year in the Year-to-Date (YTD) period. Oral Care, a traditional stronghold, also saw growth at 21.4% year-on-year.
Sustainability remains a key focus, with 41% of EPL's portfolio now comprising sustainable tubes. The company achieved the EcoVadis Platinum Rating, placing it among the top 1% of companies globally for sustainability. Several of its sites are certified as Zero-Waste to Landfill, and it retained a top 'A' rating in supplier engagement. EPL was also recognized on the CDP Climate & Water A List 2025.
In terms of future outlook, EPL aims for high teens growth in the coming quarters, driven by continued B&C momentum and pricing benefits. The company is also progressing with the merger of EPL and Indovida, with an indicative timeline for completion in Q4 FY27, subject to regulatory approvals. The merger aims to create a consumer packaging leader for emerging markets. EPL is actively managing the Middle East crisis by ensuring supply security and protecting profitability through full pass-through of cost inflation.
What to do with a filing like this
EPL Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by EPL Limited. Read the original for the full detail.